Yahoo Finance EN

EUDA Health price target lowered to $2.75 from $6 at Greenridge

Mar 10, 2026 &03001010202631; 14:00 UTC finance.yahoo.com Trending 4/5

Read original on finance.yahoo.com ↗

↘

Negative for markets

Sentiment score: -75/100

High impact Immediate effect (hours)

WHAT THIS MEANS

Greenridge significantly lowered EUDA Health's price target by 54% from $6.00 to $2.75, signaling substantial downside risk and loss of analyst confidence in the company's near-term prospects. This dramatic reduction suggests deteriorating fundamentals or revised growth expectations.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

EUDA

EUDAStock

Expected to decline

Major price target cut of 54% indicates significant downside pressure and analyst reassessment of company valuation and growth trajectory

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Investors holding EUDA should reassess positions given the substantial target reduction. Consider taking profits or reducing exposure, as the stock faces significant downside risk toward the $2.75 level. Monitor for additional analyst downgrades that could accelerate the decline.

KEY SIGNALS

Dramatic price target reduction signals loss of confidence54% downward revision suggests material negative catalyst or guidance missPotential overvaluation correction from previous $6 targetRisk of further downside if stock trades above new target

SECTORS INVOLVED

HealthcareBiotechnology

Analysis generated on Mar 11, 2026 at 02:06 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Yahoo Finance. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

EUDA Health price target lowered to $2.75 from $6 at Greenridge

RELATED INTELLIGENCE